Huska Brenda, Ulanova Marina
Medical Sciences Division, Northern Ontario School of Medicine University, Thunder Bay, ON P7B 5E1, Canada.
Pathogens. 2025 Feb 21;14(3):210. doi: 10.3390/pathogens14030210.
Non-typeable (NTHi) is often asymptomatically carried in the upper airways but can cause a wide spectrum of disease conditions, from local respiratory tract infections to invasive disease such as sepsis or meningitis. The factors driving NTHi's transition from benign carriage to severe systemic disease remain poorly understood. It is unknown whether NTHi strains associated with invasive or non-invasive disease differ in their capacity to trigger inflammatory responses in innate immune cells. To address this question, we have used an in vitro infection model of human THP-1 cells differentiated to macrophages. To evaluate inflammatory responses, we studied the expression of 3 prototypic pro-inflammatory molecules, ICAM-1, TNF-α, and IL-1β. The role of lipooligosaccharide in triggering inflammatory responses was assessed using inhibition of Toll-like receptor 4 signaling. Our experiments demonstrated that NTHi strains isolated from cases of invasive and non-invasive infections were similarly able to induce strong activations of macrophage pro-inflammatory responses. Our findings support the hypothesis that the development of invasive versus non-invasive NTHi disease may be more significantly influenced by the adaptive immune response than the innate immune response.
不可分型流感嗜血杆菌(NTHi)通常在上呼吸道无症状携带,但可导致多种疾病,从局部呼吸道感染到败血症或脑膜炎等侵袭性疾病。驱动NTHi从良性携带转变为严重全身性疾病的因素仍知之甚少。与侵袭性或非侵袭性疾病相关的NTHi菌株在触发先天免疫细胞炎症反应的能力上是否存在差异尚不清楚。为了解决这个问题,我们使用了分化为巨噬细胞的人THP-1细胞的体外感染模型。为了评估炎症反应,我们研究了3种典型促炎分子ICAM-1、TNF-α和IL-1β的表达。使用Toll样受体4信号抑制来评估脂寡糖在触发炎症反应中的作用。我们的实验表明,从侵袭性和非侵袭性感染病例中分离出的NTHi菌株同样能够诱导巨噬细胞促炎反应的强烈激活。我们的研究结果支持这样一种假设,即侵袭性与非侵袭性NTHi疾病的发展可能受适应性免疫反应的影响比先天免疫反应更显著。